APA (7th ed.) Citation

Guo, L., Zhou, G., Huang, M., Tang, K., Xu, J., & Chen, J. (2024). The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non‐small cell lung cancer: A meta‐analysis. Clinical Respiratory Journal, 18(4), 1. https://doi.org/10.1111/crj.13748

Chicago Style (17th ed.) Citation

Guo, Liuxian, Guojin Zhou, Min Huang, Kejing Tang, Jing Xu, and Jie Chen. "The Impact of EGFR T790M Mutation Status Following the Development of Osimertinib Resistance on the Efficacy of Osimertinib in Non‐small Cell Lung Cancer: A Meta‐analysis." Clinical Respiratory Journal 18, no. 4 (2024): 1. https://doi.org/10.1111/crj.13748.

MLA (9th ed.) Citation

Guo, Liuxian, et al. "The Impact of EGFR T790M Mutation Status Following the Development of Osimertinib Resistance on the Efficacy of Osimertinib in Non‐small Cell Lung Cancer: A Meta‐analysis." Clinical Respiratory Journal, vol. 18, no. 4, 2024, p. 1, https://doi.org/10.1111/crj.13748.